Physician profile
David Edwards
NPI 1730253220
$1,394.65
in general payments reported to CMS, 2019-2025
14 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $142 · 2021: $349 · 2022: $307 · 2023: $222 · 2024: $61.24 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407 · Education: $57.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.37 |
| Education | $57.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $401.85 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $306.68 | 2019-2025 | Dupixent |
| Acclarent, INC | $231.41 | 2019-2023 | Acclarent Aera |
| Intersect Ent, INC. | $90.24 | 2021 | |
| Stryker Corporation | $83.49 | 2022-2023 | Audion Et Dilation System, Xpress Ent Dilation System, Scopis Ent |
| Genzyme Corporation | $73.19 | 2021-2025 | |
| Allergan, INC. | $65.01 | 2019 | |
| Boston Scientific Corporation | $39.59 | 2021 | |
| Kaleo, INC. | $29.95 | 2021-2022 | |
| Novo Nordisk INC | $19.99 | 2024 | Wegovy |
| Smith+Nephew, INC. | $16.71 | 2019 | |
| Baxter Healthcare | $14.57 | 2022 | |
| Glaxosmithkline, LLC. | $13.94 | 2021 | |
| Aerin Medical INC. | $8.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.